Revolution Medicines
RVMD
$37.25
Share price
-0.53%
Change (1 day)
45.39%
Change (1 year)
Categories
P/S ratio for Revolution Medicines (RVMD)
P/S ratio as of May 2024 (TTM): 528
According to Revolution Medicines 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 527.585. At the end of 2023 the company had a P/S ratio of 406.
P/S ratio history for Revolution Medicines from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 406 | 578.62% |
| 2022 | 59.8 | -5.27% |
| 2021 | 63.1 | 3.22% |
| 2020 | 61.1 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |